ロード中...
Tofacitinib in the treatment of ulcerative colitis: efficacy and safety from clinical trials to real-world experience
Tofacitinib is an oral small molecule directed against the JAK/STAT pathway, blocking the inflammatory cascade. Oral formulation of tofacitinib has recently been approved for the treatment of patients with moderate–severe ulcerative colitis. Its efficacy and safety have been demonstrated in three ph...
保存先:
| 出版年: | Therap Adv Gastroenterol |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6535722/ https://ncbi.nlm.nih.gov/pubmed/31205486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819848631 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|